Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Stock (NASDAQ:AGIO), Quotes and News Summary
Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 356.266K | Mkt Cap1.381B |
| Day Range- - - | 52 Wk Range21.070 - 31.860 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.690 | (EXPECTED) 2023-11-02 | |||||
| REV | 7.910M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.600 | -1.510 | 0.0900 | ||||
| REV | 6.670M | 6.712M | 42.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-07 | JP Morgan | Tessa Romero | Maintains | NeutralNeutral | Lowers | 33.00 | 32.00 |
| 2023-06-27 | RBC Capital | Kennen MacKay | Maintains | OutperformOutperform | Raises | 40.00 | 42.00 |
| 2023-02-03 | Piper Sandler | Christopher Raymond | Initiates Coverage On | Overweight | Announces | - | 41.00 |
| 2022-12-01 | JP Morgan | Tessa Romero | Maintains | Neutral | Lowers | 48.00 | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals | 0% | 1.4B |
| IDYA | IDEAYA Biosciences | 0% | 1.5B |
| ZNTL | Zentalis Pharma | 0% | 1.4B |
| SAGE | Sage Therapeutics | 0% | 1.2B |
| XNCR | Xencor | 0% | 1.2B |
How do I buy Agios Pharmaceuticals (AGIO) stock?
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Who are Agios Pharmaceuticals's (AGIO) competitors?
Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Agios Pharmaceuticals (AGIO) stock?
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Monday, August 7, 2023. The analyst firm set a price target for 32.00 expecting AGIO to rise to within 12 months (a possible 29.19% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Agios Pharmaceuticals (AGIO)?
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $24.77 last updated September 28, 2023 at 8:00 PM UTC.
Does Agios Pharmaceuticals (AGIO) pay a dividend?
There is no dividend information for Agios Pharmaceuticals.
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Agios Pharmaceuticals (AGIO) going to split?
There is no upcoming split for Agios Pharmaceuticals.
What sector and industry does Agios Pharmaceuticals (AGIO) operate in?
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.